Thai agency branches into EVs from renewable power

Many people expect electric vehicles to become a fixture in a future world that relies on renewable energies. But not many EV companies started out as renewable energy companies.

One company trying to accomplish this feat is Energy Absolute, based in Bangkok. The biodiesel maker and renewable energy company entered the commercial electric vehicle business in 2019.

In March of this year, Thailand set a goal of having one million electric vehicles on its roads by 2025 – and hopes that number will climb to 15 million a decade later. This includes not only private cars, but also commercial vehicles – delivery vans, trucks, buses and the like.

A former securities dealer, Somphote Ahunai, founded Energy Absolute in 2006. He listed the company in Thailand in 2013 and began expanding into energy storage in 2016 when the company acquired shares in Taiwanese company Amita Technologies, a manufacturer of energy storage systems. It is now in the final stages of building a $ 3 billion battery gigafactory project to manufacture lithium-ion batteries.

Ahunai told CNBC’s “Managing Asia” that the government’s efforts to encourage the adoption of electric vehicles in Thailand helped him get the project started, and now he says he is urging the government to “open up the market and get one.” to create favorable policies for the electric vehicle market “.

However, the pandemic has affected the company’s push toward electric vehicles. An order for 3,500 five-seat hatchbacks was canceled by a local taxi company as tourism dried up. Ahunai made a quick pan to focus on utility vehicles and battery storage instead.

“A lot of manufacturers are focusing on the passenger car. Not many people are focusing on the commercial vehicle yet because they can’t overcome how to charge the vehicle faster and the battery last longer,” said Ahunai.

Ahunai plans to install 1,000 charging stations across the country in the next few years.

A charging sign is located at an Energy Absolute Anywhere charging station in Bangkok, Thailand, 2019.

Nicolas Axelrod | Bloomberg | Getty Images

“We have introduced nearly 500 charging stations across the country, mainly in Bangkok and the surrounding area,” said Ahunai, adding that the company holds nearly 80% of the market share of charging stations in Thailand.

His focus on commercial vehicles is in line with Thai policy of putting around 70,000 electric commercial vehicles on the road every year.

Read more about electric vehicles from CNBC Pro

“If we back up successfully [the commercial electric vehicle] Segment … then we create economies of scale so that we can move into the other segments, “said Ahunai.

Japanese, American, and German automakers have all made vehicles in Thailand, but despite the country’s auto-building expertise, it does not have its own internationally recognized vehicle brand. Ahunai said he believed electric cars could change that. He wants Energy Absolute to be at the center of that effort.

“We believe that by using [our] Technology and Thailand [auto-making] Infrastructure, we can use that as a stepping stone to the world market, “said Ahunai.” At least we can penetrate the ASEAN market with almost 600 million inhabitants. So that’s a good market for us at the beginning. “

At the moment, most of the company’s revenue comes from renewables like wind and solar, but Ahunai said his foray into commercial electric vehicles will be an important source of income for the future.

“If you look at what we are investing [in] Now, “he said,” it will completely change the company’s revenue structure in a few years. “

Hedge fund sells stake in Trump SPAC agency DWAC after merger information

At least one hedge fund has its stake in the SPAC. sold Digital World Acquisition Corp. after The company announced plans to merge with the social media company planned by the former president Donald Trump.

Lighthouse Investment Partners, one of at least nine hedge funds that hold shares in Digital World Acquisition, abandoned its stakes in this particular acquisition company after learning of its merger with Trump’s Venture, the fund told CNBC on Friday.

Lighthouse owned 3.2 million shares, or 11.2% of the SPAC, according to a government filing dated Sept. 30.

“Lighthouse was unaware of the upcoming merger and no longer holds unrestricted shares in SPAC,” the fund said. When asked if Lighthouse had benefited from its DWAC investment, the company said it would not comment.

The sell-off came when DWAC saw that a huge surge in stock price on Thursday following the merger news.

DWAC shares up more than 100% on Friday after the share price more than quadrupled in the previous session.

It’s not clear whether the hedge fund was sold to capture profits from its stake in DWAC or whether it was concerned about the risk of being associated with Trump, who was twice indicted and accused as president of the fatal one For instigating the January 6th Capitol Rebellion among his followers.

The social media app is developed by the Trump Media and Technology Group (TMTG).

Rafael Henrique | LightRakete | Getty Images

SPACs, also known as blank check companies, are formed to raise capital from the public stock markets and then use that cash to merge with a private company that has or will have an actual operating business.

The shares of this merged company will then be traded under the stock market ticker created by SPAC.

Investors in SPACs are generally unaware of the identity of the other company being considered for a merger.

Among the other hedge funds listed as major DWAC shareholders in September, DE Shaw owned 8% of SPAC, or 2.4 million shares, while ARC Capital held nearly 18%, or 6.6 million shares.

Other funds that held stakes in the last month prior to the announcement of the merger were Saba Capital Management, Highbridge Capital Management, Lighthouse Investment Partners, K2 Principal Fund, ATW Spac Management, Boothbay Fund Management, and RG Capital Management.

Highbridge Capital Management and ATW Spac Management declined to comment when asked if they would keep shares in DWAC, and the rest of the hedge funds did not immediately respond to CNBC’s requests for comment.

Another fund listed as a major DWAC investor is ARC Global Investments II, LLC.

The executive member of ARC Global is listed in a government filing as Patrick Orlando, who is also the CEO of DWAC.

CNBC policy

Read more about CNBC’s political coverage:

In an 8-K filing with the Securities and Exchange Commission on Thursday, DWAC announced that it had entered into an agreement and merger plan with DWAC Merger Sub Inc., a wholly owned subsidiary of DWAC, and Trump Media & Technology Group ARC Global Investments II.

Trump’s company, the previously unstarted Trump Media & Technology Group, said in an announcement on Wednesday that his “mission is to create a rival for the liberal media consortium and to fight back against the ‘big tech’ companies of Silicon Valley that have used their one-sided power to silence opposing voices in America.”

Trump was banned from Twitter, his favorite social media platform, and Facebook earlier this year after he was accused of sparking the Capitol invasion.

A top post on the WallStreetBets forum on Friday revealed what the user’s stock portfolio looked like and touted daily winnings of over $ 10,000 from wagering on DWAC. The post calling the former president “Daddy Trump” quickly drew more than 800 comments.

This is the latest news. Check back for updates.

Fintech agency Smart service permits customers in India to ship cash overseas

In this photo illustration, the TransferWise logo is displayed on an Android mobile phone.

Omar Marques | SOPA Pictures | LightRakete | Getty Images

Financial technology company Wise said Tuesday that users in India can now send money overseas to 44 countries around the world.

This includes places like Singapore, Great Britain, the United States, the United Arab Emirates, as well as countries in the euro zone.

India’s overseas remittances for the 2019-2020 fiscal year were approximately $ 18.75 billion, of which more than 60% were categorized under Travel and Study Abroad Payments. according to the Reserve Bank of India. Under a liberalized remittance system, the central bank allows residents to freely transfer up to $ 250,000 per fiscal year abroad to fund personal expenses or education – which begins in April and ends in March of the following year.

Typically, the overseas remittance market is comparatively larger, as many Indians who work overseas send money back to their families in the country. World Bank data for 2019 shows personal transfers in India over $ 83 billion.

Kristo Kaarmann, CEO and co-founder of Wise, previously called TransferWise, told CNBC that the ability to send money from India was one of the most requested services the company was getting from users.

“India in particular is very exciting,” said Kaarmann. “In the last, almost ten years, the establishment of a local payment infrastructure and UPI has been very interesting to watch.”

Unified Payments Interface or UPI is one of the dominant methods for digital payments in India. What sets the framework apart from mobile wallets is its interoperability – this means that people can use different platforms based on UPI to send money and conduct financial transactions.

London-based Wise specializes in cross-currency money transfers that can be done entirely online. It claims its service is faster and cheaper than other fintech players as well as traditional banks, which are prone to big cuts and offer unfavorable exchange rates.

Banks are the dominant platform for international money transfers in India.

Wise partnered with Google Pay last month so that users in the US can send money to India.

Wise also announced the opening of a local office in Mumbai on Tuesday. Kaarmann declined to give details of possible partnerships in the plants in India.

No agency plans but for Parkersburg Rescue Plan cash | Information, Sports activities, Jobs

Charles Roberts, from the Parkersburg area, speaks during the public forum at the Parkersburg City Council meeting Tuesday on the funding the city will receive from the US rescue plan. (Photo by Evan Bevins)

PARKERSBURG – With more than $ 22 million in American Rescue Plan funds flowing into the city of Parkersburg this year and next, discussions are ongoing about how that money will be spent.

“I hope the Council will agree to use these funds to have the greatest community impact and the longest impact.” Mayor Tom Joyce said.

Officials are working to understand the rules for using the money from the US $ 1.9 trillion bailout plan passed by Congress in March. They’re listed in a tentative closing rule that Joyce said could still be changed and updated.

Permissible uses for the funds are:

* Assisting households, small businesses, nonprofits and industries such as tourism, travel and hospitality affected by the COVID-19 pandemic.

Kim van Rijn, a resident of Parkersburg, suggests using the funds from the American rescue plan that the city will receive during the public forum at the Parkersburg City Council meeting on Tuesday. (Photo by Evan Bevins)

* Providing bonuses to key workers during the public health emergency.

* Paying for government services impacted by COVID-19-related revenue declines.

* Make necessary investments in water, sewage or broadband infrastructure.

Using the money in the Parkersburg Utility Board’s planned water system improvements could reduce the rate increase required to pay for the work.

“I am shocked when the city council does not provide funding to the utility board.” said Joyce, who as mayor is the chair of the PUB.

Continuing with recent improvements in rainwater is another use Joyce would like to pursue.

Infrastructure projects provide jobs and the money is then recycled when it is spent in the community, Joyce said.

“I am in favor of bringing as much money as possible to the workers and companies that can be helped.” he said.

The mayor said he felt for people who lost their jobs and were unable to work due to the pandemic, but support such as increased unemployment benefits was available for them.

“When was the last time there was a federal program that rewarded people for going to work?” he said. “I think there is an opportunity to offer something to these people.”

It will be up to the council to determine which forum will discuss the issue and how the public can weigh itself, Joyce said.

“What we are doing now is just trying to educate ourselves about what we can and cannot use the funds for.” Council Chairman Zach Stanley said. Once the final guide is published, “Then we’ll work on how we get feedback.”

Some people have already started offering ideas.

During the council meeting on Tuesday, Kim van Rijn, who lives in Parkersburg, suggested that the city hire a director for cultural development to support organizations “They urgently need help if they want to survive.” The person could help write scholarships and raise funds for facilities such as the Sumnerite Museum on Avery Street, the Oil and Gas Museum, and Parkersburg Homecoming.

While tourism is an industry that is eligible for funding, it is not clear if funding such a position would be an acceptable use of the money.

The funds cannot be used to offset lower tax rates, but Charles Roberts, who lives outside the city limits, asked during the public forum if it could be done instead “Get rid of the usage fee.” If that is not possible, the city must diligently deal with the money that ultimately comes from taxpayers.

Joyce said the city will comply with all federal regulations on the money and it can be checked through an audit. The West Virginia Auditor’s Office has put in place mechanisms and tools to help cities, he said.

Around half of the funds will not be available until 2022. Joyce warned against tying up all of the money before the full economic impact of the pandemic is known. Federal guidelines shared by the office of U.S. Senator Joe Manchin, DW.Va. state that the reduction in revenue can be calculated at four different times: December 31, 2020, 2021, 2022, and 2023.

“This approach recognizes that some beneficiaries may experience the delayed impact of the pandemic on revenue.” the document says.

Evan Bevins can be reached at ebevins@newsandsentinel.com.

Get the latest news and more in your inbox

Corwin Legislation Agency Recordsdata Class Motion Lawsuit towards Occasion Leisure Group, Metropolis of Miami over COVID Cancellation of the 2020 Extremely Music Pageant

MIAMI, April 1, 2021 / PRNewswire / – Corwin Law, a consumer rights law firm based in Boca Ratonhas filed a class action lawsuit against Event Entertainment Group and the City of Miami on behalf of Florida Residents who bought tickets for the 2020 Ultra Music Festival that was supposed to take place March, 20th – 22, 2020 at Bayfront Park in Miami Beach.

Lawyer Marcus W. Corwin stated that the 2020 festival cancellation was disguised as a postponement due to the COVID-19 pandemic, with the promise of an expanded package of benefits for the 2021 festival for ticket buyers in lieu of refunds. After the 2021 event was canceled, the event organizers reached out to ticket holders again to make further promises but still no refund.

“It is completely irresponsible for the organizers to withhold refunds for more than two years, and for the City of Miami with no guarantee that this event can take place in 2022 or 2023, “Corwin said.

“This is an abuse of fairness and accepted and proper trading practice,” Corwin continued. “Nobody argues that the festival should have continued, but if it didn’t, the organizers should have refunded the money. If ticket holders want to attend the festival, they can choose and pay on their own terms.” “

After the class action lawsuit with eight counts filed in the Eleventh Judicial District in Miami-Dade County, “Ultra engages in intangible, unfair, and / or misleading trading practices by promoting, offering, and promoting the festival, taking the money from individuals to attend the advertised festival, canceling the festival, and then not allowing ticket buyers to receive it a refund, effectively shifting all of the risks and costs of Ultra’s decision to cancel the event to consumers. “

Gabriella PetrokaThe class representative stated, “As a longtime loyal participant, I am grateful to Ultra for making many amazing memories possible, and I hope Ultra will last for many years to come. However, I also hope Ultra will do the same.” Please consumers by giving us the choice of getting refunds and our own choice of how to use that money and whether or not to attend future events as I believe that, given the indescribable duration, that is the only thing fair result is this ‘shift’. “

Corwin, who has been practicing since 1986, has successfully fought Madonna, Live Nation, AT&T, Comcast, HBO and others, validating the offer to replace old tickets with new tickets for dates that were not confirmed as “totally unacceptable” .

The Corwin lawsuit is filing # 124094995 with the Miami-Dade County, Florida Circuit Civil Division.

This is not a solicitation of an invitation to members of the class to join the litigation. NO CLASS HAS BEEN CERTIFIED IN THE ABOVE PROMOTION. Until a class is certified, you will not be represented by an attorney unless you keep one. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT.

For further information please contact CORWIN LAW AT [email protected]

Marcus Corwin
Lawyer
Corwin Law
[email protected]

This version was published via WebWire®. For more information, visit https://www.webwire.com.

SOURCE Corwin Law

Bragar Eagel & Squire, P.C. is Investigating Tencent Music Leisure Group on Behalf of Tencent Stockholders and Encourages Buyers to Contact the Agency

TipRanks

Wells Fargo: 2 Strong Stocks With Upward Potential Above 70%

Wells Fargo analysts have scrutinized the market, or specifically the winners and losers of current market conditions. In a recent release, senior equity analyst Chris Harvey writes, “The risk and outperformance of small caps have made this stock market a haven for stock pickers.” Obviously, Harvey sees that small-cap stocks are doing well right now and are doing well for investors numerous options are available to choose from. While small caps are generally a riskier investment, one distinct advantage over bigger names is the potential for higher returns. This is where the risk / reward paradigm comes into play. Following Harvey’s tip, the company has made a number of recommendations and found small-cap stocks on the cusp of growth that promise a return of 70% or more for the coming year. We ran two of them through the TipRanks database to see what other Wall Street analysts were up to. Ping Identity Holding (PING) Based on the technology industry, Wells Fargo’s first pick is Ping Identity Holding Corp, which specializes in identity management. The company offers a range of products that customers can use to control login and access to networks and databases. While Ping Identity has been in business for nearly 20 years, it has only been a public company for a year and a half. In the company’s most recent quarterly report for the fourth quarter of 2010, Ping reported mixed results, and immediately posted a 20% decline in price. The EPS was a net loss of 4 cents per share. Revenue was down 7% year-over-year to $ 63.2 million, but increased 5.5% sequentially, marking the second highest quarterly revenue the company has had since going public. For the full year, total revenue was $ 243.6 million, driven by a 15% increase in annual recurring revenue (ARR) year over year, which hit $ 259.1 million. The company saw a 34% increase in customers with an ARR of more than $ 1 million, a solid win on one key metric. Wells Fargo analyst Philip Winslow was particularly impressed with the ARR gain. “Ping reported solid fourth quarter results, with ARR exceeding expectations. The 15% year-over-year ARR growth was above consensus estimates of $ 256.1 million due to continued adoption of SaaS solutions, which accelerated more than expected and accounted for + 15% of total ARR, ” wrote the 5-star analyst. Winslow added, “The company is seeing continued signs of pent-up demand as customers phased out their purchases as projects previously suspended from COVID budget pressures emerge in the pipeline and companies modernize legacy systems whose flaws are exposed been the past year. “To this end, Winslow rates PING as overweight (i.e. buy) and has a target price of $ 40, indicating upside potential of 76% over the next 12 months. (To see Winslow’s track record, click here.) Winslow is not an outlier in his bullish stance, but there is some divide on Wall Street over ping. The analysts’ consensus view is a moderate buy based on a dozen ratings that consisted of 7 buys and 5 holds The shares are priced at $ 22.59 and their average target price of $ 33.71 indicates a year-long share Upward movement of 49%. (See PING stock analysis on TipRanks.) Sangamo Therapeutics (SGMO) Let’s shift gears and take a look at the life science sector. Sangamo is a biotechnology company focused on developing genomic therapies to treat genetic diseases. The company’s pipeline includes 17 different programs at various stages of development that target a range of diseases, including IBD, beta thalassemia, sickle cell disease and hemophilia A. Back in December, the company reported an update on its ongoing collaboration with Pfizer on Giroctocogene fitelparvovec. This is a gene therapy product that is being developed to treat haemophilia A. Follow-up data from the Phase 1/2 Alta study indicated that the drug was well tolerated and safe in the small cohort of patients tested. Giroctocogene fitelparvovec is now starting the patient dosage phase of the phase 3 AFFINE study. In February, Sangamo reported that it had entered into a global partnership with Biogen to develop and commercialize new therapies for gene regulation. The therapies under consideration target Alzheimer’s, Parkinson’s and other neurological diseases. The bulls include Wells Fargo analyst Yanan Zhu, who wrote of the bigger picture: “Overall, we continue to see significant upside in the company’s genomic drug pipeline programs and platforms, particularly the regulatory T (Treg) cell therapy platform may target a wide range of autoimmune diseases and the ZFP-TF gene regulatory platform, which may target certain difficult-to-target neurological indications… ”In light of these comments, Zhu reiterates the company’s overweight (i.e. buy) rating on the stock and set up target price $ 29, suggesting a robust upward move of 158%. (To see Zhu’s track record, click here.) Overall, SGMO has shown optimism and caution about the consensus view among sell-side analysts. Out of 5 analysts surveyed over the past 3 months, 2 are bullish about the stock while 3 continue to fail. The bulls have the edge, however, as the average price target is $ 19.40 and indicates a 72% uptrend. (See SGMO stock analysis on TipRanks.) To find great ideas for trading stocks at attractive valuations, visit TipRanks’ Best Stocks to Buy, ‘a newly launched tool that brings together all of TipRanks’ stock insights. Disclaimer: The opinions expressed in this article are solely those of the presented analysts. The content is intended to be used for informational purposes only. It is very important that you do your own analysis before making any investment.

Electrical automobile agency Lucid Motors to go public in $11.eight billion blank-check merger

The Lucid Air sedan, which is slated to go into production at a facility in Arizona next year.

Clear

Electric vehicle company Lucid Motors plans to go public with a combined stock valuation of $ 11.75 billion and a pro forma stock value of $ 24 billion through a reverse merger with a blank check company founded by veteran investment banker Michael Klein.

The deal between Lucid of Newark, California and Churchill Capital Corp IV is the largest in a series of such amalgamations involving EV companies and blank check companies, also known as Special Purpose Acquisition Companies (SPACs).

Previous SPAC dealt with EV startups like Nikola, Fisker and Lordstown Motors scored less than $ 4 billion in pro forma valuations, but Lucid is ahead of these companies. Lucid will deliver its first vehicle – a Luxury sedan called Air – this spring.

The deal will generate approximately $ 4.4 billion in cash for expansion plans for Lucid, including the current Arizona factory.

Shares of CCIV fell around 30% to $ 40 in expanded trading.

Lucid is run by ex-Tesla Technical director and automotive veteran Peter Rawlinson, who joined the company in 2013 as Chief Technology Officer before adding CEO to his duties in April 2019. He will continue to assume these roles after the business is expected to close in the second quarter, according to the companies.

Lucid was founded in 2007 as Atieva, a name it now uses for its technical and engineering division that supplies batteries for the Formula E electric circuit. The company initially focused on electric battery technology before changing its name to an electric vehicle manufacturer in 2016, three years after Rawlinson joined the company to lead technology development.

Lucid struggled with some difficulty raising capital to fund his plans until he received $ 1 billion from the Saudi Arabian sovereign wealth fund in September 2018.

Rawlinson described SPAC deals last year as easy money, but not enough capital to get a vehicle into production, which companies like Fisker To seek contract manufacturers.

Prior to the announcement at Klein’s company, Rawlinson said the company had the funds to begin producing the air at a facility in Casa Grande, Arizona, southeast of Phoenix.

The new funding is intended to support Lucid in its expansion plans. Rawlinson expects the Air to be the catalyst for a number of future all-electric vehicles, including an SUV starting production in early 2023, and cheaper vehicles across the board.

Lucid currently employs almost 2,000 people. The US is expected to employ 3,000 people domestically by the end of 2022.

The deal includes a total investment of around $ 4.6 billion. It is funded with $ 2.1 billion in cash from CCIV and a fully committed PIPE of $ 2.5 billion at $ 15 per share from the Saudi Arabian state fund, as well as funds and accounts held by BlackRock, Fidelity and managed by others.

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Invitations GameStop Corp. (GME), AMC Leisure Holdings, Inc. (AMC) and BlackBerry Ltd. (BB) Buyers to Contact its Attorneys, Agency Investigating On-line Brokerages’ Market Manipulation Scheme

TipRanks

Those 2 penny stocks could rally as much as $ 11, analysts say

At its FOMC meeting in January, the Federal Reserve held rates stable – they are currently near their lows, and unsurprisingly, the Fed is holding them there. Fed chairman Jerome Powell may have fed some market pessimism when speaking after the meeting, pointing out that unemployment has risen in recent months. For market watchers seeking support, there is consolation in the Fed’s monetary policy. The central bank has pledged to buy $ 80 billion worth of Treasury bills every month and has put a rate hike on hold until 2023. At least one top strategist sees the current market environment in terms of opportunities. JPMorgan strategist Marko Kolanovic takes an optimistic stance and writes: “We assume that the global COVID pandemic will decline rapidly in the coming weeks. In fact, the pace of decline in new cases in the past two weeks is the fastest ever in the US and worldwide. Central banks should remain accommodative amid rising unemployment and over a decade of low inflation that is below their targets – term turmoil like this week offers an opportunity to switch from bonds to stocks. “With that outlook in mind, we set out to find exciting opportunities that won’t break the bank, namely penny stocks. Priced at $ 5 or less, these stocks offer investors the highest growth potential available in the market. Again, there is a risk, as the “pennies” are often cheap for a reason. Careful examination is therefore essential. Using TipRanks’ database, we identified two penny stocks that received a consensus rating of “Strong Buy” from the analyst community. Not to mention, every company has huge upside potential as some analysts see it spike to $ 11. BioLineRx, Ltd. (BLRX) We’re starting BioLineRx, a clinical-stage biopharmaceutical company focused on developing new cancer treatments. Oncology is an important area for state-of-the-art biopharmaceuticals. Cancer is often fatal and often resistant to topical treatments – and these treatments themselves often cause severe side effects in patients. BioLineRx has an active pipeline of drug candidates. The most advanced, however, is motixafortid, a synthetic peptide that has completed patient enrollment in a phase 3 study to mobilize stem cells for autologous bone marrow transplantation. The drug is being studied for effectiveness in promoting bone marrow harvesting prior to cancer treatment. The results of a pre-planned interim analysis showed “statistically significant evidence for motixafortid treatment at the primary endpoint” so significant that enrollment was completed early with 122 patients instead of 177. Mobilizing stem cells using Motixafortid is believed to be the company’s most efficient route to registering the new drug for regulatory approval. Given the potential of Motixafortide and its share price of $ 2.40, some analysts believe now is the time to pull the trigger. Mark Breidenbach, 5-star analyst, reported on BLRX for Oppenheimer: “Our thesis continues to focus on motixafortid in the mobilization of stem cells, and we see a separation between the company’s market capitalization and the market opportunity of Motixafortid as a stem cell mobilizer. The key GENESIS secondary endpoints are expected by mid-2021 and we see little risk for this data … “The analyst added,” We believe the results of the Phase 3 GENESIS trial will prompt the majority of transplant doctors might choose to combine BL-8040 with G-CSF instead of Mozobil if the drug is approved. In addition to our work, BL-8040 contains for use in other auto-HSCTs, allo-HSCTs, AML, and solid tumors. The company has a catalyst-rich, deep oncology pipeline that has attracted collaborations with Novartis, Merck and Genentech. “With all of this in mind, Breidenbach rates BLRX as a buy, and its target price of $ 11 points to an uptrend of a whopping 358% for the coming year. (To see Breidenbach’s track record, click here.) The rest of the street seems to reflect Breidenbach’s bullish sentiment. With 3 buys and no holds or sells, the consensus is unanimous: BLRX is a strong buy. On top of the good news, the upside is ~ 428% based on the average price target of $ 12.67. (See BLRX stock analysis on TipRanks) Kindred Biosciences (KIN) While most biotech companies focus on human drugs, we’re not the only market. Kindred Biosciences is a biopharmaceutical company in the veterinary marketplace developing biological medicines to improve the lives of our pets and work animals. The company describes its mission as'[bringing] Pet the same safe and effective medications that human family members enjoy. Parvovirus (CPV) is a highly infectious and fatal viral disease that affects dogs. While vaccines are available, untreated cases can have a mortality rate of over 91%. Kindred’s lead drug in the pipeline, KIND-030, is currently in development for the treatment of this disease. The drug candidate is currently pursuing two paths in the development process – one for the treatment of established infections and one for the prophylactic preventive treatment of CPV. The prophylactic study showed positive results, with all dogs treated avoiding infection while all dogs in the placebo group developed parvovirus disease. KIND-030 also showed a mortality benefit when given to treat infections. The drug candidate is in the crucial study phase of development, the last before possible approval. Last month, Kindred announced it had entered into an agreement with Elanco Animal Health, a major veterinary drug company, to manufacture KIND-030. Cantor analyst Brandon Folkes sees a lot of potential in Kindred, especially in the company’s agreement with Elanco. “A partnership with a leading animal health company, in this case Elanco, is exactly what the company needs from our point of view. This confirms, in our view, KIN’s new strategic approach as a drug developer to find larger trading partners. We believe today’s deal should show investors that Kindred’s pipeline continues to have significant value that could be realized in the next 12 to 18 months, ”said Folkes. Kindred is also conducting studies with tirnovetmab, or KIND-016, an antibody directed against IL31, for the treatment of atopic dermatitis in dogs. The pivotal efficacy study of this drug began in the final quarter of 2020. There is a potentially huge market for successful dermatitis treatment in dogs. Over the past six years, there has been a 47% increase in veterinary visits for dogs with severely itchy skin and the market is valued at $ 900 million or more. “While 2020 was a tough year for KIN stock, the company continued to take several shots on goal from its diversified pipeline that could reward investors at current levels. With multiple readings in 2021 and once again focusing solely on developing its pipeline, we anticipate that 2021 could be a banner year for KIN should it be able to deliver on the promise of its pipeline and, in particular, its atopic dermatitis portfolio, ” so the analyst summarized. To do this, Folkes gives KIN a price target of $ 11, which means an upside of 139% in 2021 and an overweight (i.e. buy). (To see Folkes’ track record, click here.) Kindred is another company with a unanimous consensus from Strong Buy analysts based on 5 recent Buy ratings. The stock has an average price target of $ 10.25, indicating ~ 124% growth from the current trading price of $ 4.59. (See KIN Stock Analysis on TipRanks.) To find great ideas for trading penny stocks at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that brings together all of the insights into TipRanks stocks. Disclaimer: The opinions expressed in this article are solely those of the presented analysts. The content is intended to be used for informational purposes only. It is very important that you do your own analysis before making any investment.

VIDEO: French Agency Launches James Bond-Model Highway Boat On Wheels

PERROS GUIREC, France – It is a huge hassle for vacationers to carry a boat to a beach and then push it into the water. It’s a time consuming exercise.

A French company solved this problem by making an amphibious boat.

“Boat enthusiasts no longer have to spend up to two hours getting their ship into the water. You can now just take your amphibious boat to a beach and start boating right away, said Christophe Le Bitoux, sales manager. TRINGAboat, the French manufacturer of amphibious boats.

The images released by the company show the first street-compliant amphibious boat that can go in and out of the ocean in less than a minute, and it has been compared to something made of one James Bond Movie.

Bitoux said the patented amphibious boat was the first in the world to be driven on roads.

Countless people have compared the boat to something that ‘007’ would sail, Le Bitoux said, adding, “This boat would be pretty much at home in a James Bond movie, which has to do with being in no time and can walk out of the water. Park your boat in front of a casino and go in before you get out and head straight into the water – no one else can! “

He said their order book was full and that customers from around the world had shown interest.

Although the boat passed all safety tests for driving on the roads in France, it was another six years before the authorities granted approval.

Certificates of Conformity from the European Union requested, he said, adding that Brexit would in no way affect their ability to do business in the UK.

The invention can also be driven and used in the United States, such as Florida, where, according to Le Bitoux, there is often a line of boats waiting to get into the water.

In France, “the average time it takes to put a normal boat in the water is between an hour and an hour and a half.”Using his hydraulic wheel system, he said it takes less than a minute to get the boat into the water and only about two minutes after the wheel hatches close to drain the water from them.

The order book for the boat is full as customers from all over the world have shown interest. (TRINGAboat / Real Press)

Once in the water, various models of their boat, including the TRINGA T650, can travel at speeds of over 30 knots, the company’s managing director claimed.

The current wait time from order to delivery is about three months as all boats are assembled in-house and hand-top-down, Le Bitoux said.

TRINGAboat products come with indicator lights, front and rear cameras that also have night vision, windshield wipers and numerous other conveniences that one would expect from the latest models of modern cars, he said.

There are three models of the boat, all of which are very customizable. You can also interact with smartphones and connect to the internet, which makes the invention a “smartboat”.

The TRINGA T650 Armoric costs 124,900 EUR (152,193.15 USD), the TRINGA T650 Premium costs 139,900 EUR (170,470.95 USD) and the top model TRINGA T650 Exclusive costs 159,900 EUR (194,841.35 USD).

Returning to James Bond, the hero used a number of vehicles to fight his enemies. Bond’s vehicles are equipped with novel devices that enable him not only to maneuver city streets, but also harsh landscapes, seas and skies. They are armed with firearms and anti-tracking systems, etc.

An example of an amphibious bond vehicle is Lotus Esprit S1which was used by him in “The Spy Who Loved Me” (1977). His nickname is “Wet Nellie” and is loaded with weapons like cannons that spray the vehicles with wet cement as they pursue them. It also has a rocket launcher.

(Edited by Shirish Vishnu Shinde and Megha Virendra Choudhary.)